iTeos Therapeutics (ITOS) News Today $10.07 -0.11 (-1.08%) As of 04:00 PM Eastern Add Compare Share Share Headlines Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrendsBuy This Stock ITOS Latest News All Sources Trusted Sources MarketBeat Benzinga Bloomberg GlobeNewswire GuruFocus MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha TalkMarkets The Street TipRanks The Wall Street Journal Wall Street Zen Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative Most Recent July 2025 June 2025 May 2025 April 2025 March 2025 February 2025 January 2025 December 2024 November 2024 October 2024 September 2024 August 2024 July 2024 June 2024 May 2024 April 2024 March 2024 February 2024 January 2024 December 2023 November 2023 October 2023 September 2023 August 2023 July 2023 June 2023 May 2023 April 2023 March 2023 February 2023 January 2023 December 2022 November 2022 October 2022 September 2022 August 2022 Time Period iTeos Therapeutics (NASDAQ:ITOS) and Hoth Therapeutics (NASDAQ:HOTH) Head to Head ReviewJuly 7 at 4:13 AM | americanbankingnews.comiTeos Therapeutics, Inc. (NASDAQ:ITOS) Receives Average Rating of "Hold" from BrokeragesJuly 3, 2025 | americanbankingnews.comiTeos Therapeutics, Inc. (NASDAQ:ITOS) Given Consensus Recommendation of "Hold" by BrokeragesJuly 3, 2025 | marketbeat.comITOS iTeos Therapeutics, Inc. - Seeking AlphaJune 26, 2025 | seekingalpha.comiTeos Therapeutics, Inc. (NASDAQ:ITOS) CEO Michel Detheux Sells 43,883 SharesJune 12, 2025 | insidertrades.comiTeos Therapeutics, Inc. (NASDAQ:ITOS) CEO Sells $439,707.66 in StockJune 11, 2025 | marketbeat.comMichel Detheux Sells 43,882 Shares of iTeos Therapeutics, Inc. (NASDAQ:ITOS) StockJune 11, 2025 | marketbeat.comiTeos Therapeutics Inc.June 11, 2025 | barrons.comiTeos Therapeutics validates InvestingPro’s Fair Value analysis with 70% returnJune 9, 2025 | uk.investing.comiTeos Therapeutics, Inc. (NASDAQ:ITOS) Receives Consensus Recommendation of "Hold" from BrokeragesJune 8, 2025 | marketbeat.comInsider Selling: iTeos Therapeutics, Inc. (NASDAQ:ITOS) Director Sells 38,227 Shares of StockJune 7, 2025 | insidertrades.comDavid Hallal Sells 38,227 Shares of iTeos Therapeutics, Inc. (NASDAQ:ITOS) StockJune 6, 2025 | marketbeat.comiTeos Therapeutics, Inc. (NASDAQ:ITOS) Director Sells $391,454.72 in StockJune 6, 2025 | marketbeat.comMichel Detheux Sells 43,883 Shares of iTeos Therapeutics, Inc. (NASDAQ:ITOS) StockJune 6, 2025 | marketbeat.comiTeos Therapeutics, Inc. (NASDAQ:ITOS) CEO Sells $448,035.22 in StockJune 6, 2025 | marketbeat.comStocks With Rising Relative Strength: iTeos TherapeuticsJune 6, 2025 | msn.comNuveen Asset Management LLC Trims Holdings in iTeos Therapeutics, Inc. (NASDAQ:ITOS)June 6, 2025 | marketbeat.comiTeos Therapeutics, Inc. (NASDAQ:ITOS) Shares Bought by Public Employees Retirement System of OhioJune 5, 2025 | marketbeat.comQ2 EPS Forecast for iTeos Therapeutics Decreased by AnalystJune 2, 2025 | marketbeat.comMillennium Management LLC Has $3.16 Million Stock Position in iTeos Therapeutics, Inc. (NASDAQ:ITOS)June 1, 2025 | marketbeat.comiTeos Therapeutics, Inc. (NASDAQ:ITOS) Position Increased by Ameriprise Financial Inc.June 1, 2025 | marketbeat.comWedbush Lowers Earnings Estimates for iTeos TherapeuticsMay 31, 2025 | marketbeat.comiTeos Therapeutics Announces Intent to Wind Down Operations and Explore Asset Sales to Maximize Shareholder ValueMay 30, 2025 | nasdaq.comiTeos Therapeutics' (ITOS) "Equal Weight" Rating Reaffirmed at Wells Fargo & CompanyMay 29, 2025 | marketbeat.comiTeos Therapeutics (NASDAQ:ITOS) Stock Rating Lowered by WedbushMay 29, 2025 | marketbeat.comWedbush Downgrades iTeos Therapeutics (ITOS)May 29, 2025 | msn.comiTeos Therapeutics stock surges on wind-down newsMay 28, 2025 | za.investing.comiTeos Therapeutics Stock Jumps Following Operational Closure AnnouncementMay 28, 2025 | msn.comiTeos Therapeutics To Wind Down Operations, Explores Asset Sale: Retail Believes It’s ‘Worth More Selling It Off’May 28, 2025 | msn.comiTeos Therapeutics Inc.: iTeos Therapeutics Announces Its Intention to Wind Down OperationsMay 28, 2025 | finanznachrichten.deITeos Therapeutics Shares Surge on Wind Down of OperationsMay 28, 2025 | marketwatch.comiTeos plans to shut down operations after cancer therapy setbackMay 28, 2025 | reuters.comiTeos surges on plans to end operationsMay 28, 2025 | seekingalpha.comiTeos Therapeutics Announces Its Intention to Wind Down OperationsMay 28, 2025 | globenewswire.comD. E. Shaw & Co. Inc. Cuts Position in iTeos Therapeutics, Inc. (NASDAQ:ITOS)May 28, 2025 | marketbeat.com60,079 Shares in iTeos Therapeutics, Inc. (NASDAQ:ITOS) Purchased by BNP Paribas Financial MarketsMay 26, 2025 | marketbeat.comVestal Point Capital LP Sells 125,000 Shares of iTeos Therapeutics, Inc. (NASDAQ:ITOS)May 21, 2025 | marketbeat.comStonepine Capital Management LLC Buys 80,000 Shares of iTeos Therapeutics, Inc. (NASDAQ:ITOS)May 20, 2025 | marketbeat.comiTeos Therapeutics, Inc. (NASDAQ:ITOS) Stock Position Cut by Tang Capital Management LLCMay 20, 2025 | marketbeat.comQ2 Earnings Forecast for ITOS Issued By Leerink PartnrsMay 20, 2025 | marketbeat.comCubist Systematic Strategies LLC Decreases Position in iTeos Therapeutics, Inc. (NASDAQ:ITOS)May 19, 2025 | marketbeat.comiTeos Therapeutics (NASDAQ:ITOS) Stock Rating Lowered by Leerink PartnrsMay 17, 2025 | marketbeat.comLeerink Partners Reiterates "Market Perform" Rating for iTeos Therapeutics (NASDAQ:ITOS)May 16, 2025 | marketbeat.comiTeos Therapeutics, Inc. (NASDAQ:ITOS) Major Shareholder Bioventures 2018 L.P. Mpm Sells 630,191 SharesMay 16, 2025 | insidertrades.comOCONNOR A Distinct Business Unit of UBS ASSET MANAGEMENT AMERICAS LLC Purchases 59,649 Shares of iTeos Therapeutics, Inc. (NASDAQ:ITOS)May 16, 2025 | marketbeat.comJacobs Levy Equity Management Inc. Grows Stock Holdings in iTeos Therapeutics, Inc. (NASDAQ:ITOS)May 16, 2025 | marketbeat.comLeerink Partners Downgrades iTeos Therapeutics (ITOS)May 15, 2025 | msn.comiTeos Therapeutics: End To Belrestotug Program Leads To A Hold RatingMay 15, 2025 | seekingalpha.comITeos Therapeutics Shares Gain as Company Seeks Strategic AlternativesMay 14, 2025 | marketwatch.comiTeos stock rises despite clinical trial setbackMay 14, 2025 | investing.com Get iTeos Therapeutics News Delivered to You Automatically Sign up to receive the latest news and ratings for ITOS and its competitors with MarketBeat's FREE daily newsletter. Email Address ITOS Media Mentions By Week ITOS Media Sentiment Learn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. ITOS News Sentiment▼0.340.57▲Average Medical News Sentiment ITOS News Coverage Learn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. ITOS Articles This Week▼33▲ITOS Articles Average Week Get iTeos Therapeutics News Delivered to You Automatically Sign up to receive the latest news and ratings for ITOS and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies SDGR News Today EVO News Today OCUL News Today VERA News Today ETNB News Today BHVN News Today ANIP News Today MESO News Today EWTX News Today JANX News Today Headlines Tools Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NASDAQ:ITOS) was last updated on 7/7/2025 by MarketBeat.com Staff From Our PartnersA grave, grave error.I thought what happened 25 years ago was a once- in-a-lifetime event… but how wrong I was. Because here we...Porter & Company | SponsoredThis Signal Only Flashes Once Every 4 Years – And It Just TriggeredThis same signal has appeared twice before in the past 8 years — both times, it kicked off major moves in cryp...Crypto Swap Profits | SponsoredPresidential Bombshell: $150T Resource to Be Released as soon as this Summer?Something extraordinary is happening in Washington. For the first time in over a century, a sitting Preside...Paradigm Press | SponsoredBanks aren’t ready for this altcoin—are you?Our expert analysts have identified a $100 billion gap in the crypto market. Only one project is perfectly ...Crypto 101 Media | SponsoredINVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting OffRight now, we’re witnessing a monumental shift in the world.Traders Agency | SponsoredIs Elon's empire crumbling?The Tesla Shock Nobody Sees Coming While headlines scream "Tesla is doomed"... Jeff Brown has uncovered ...Brownstone Research | SponsoredMarket Panic: Trump Just Dropped a Bomb on Your Stockstock Market Panic: Trump Just Dropped a Bomb on Your Stocks The market is in freefall—and Trump's new tarif...American Alternative | SponsoredGoogle did what!?!?A new technology has sparked a modern-day gold rush in Silicon Valley. OpenAI’s Sam Altman invested $375M. Bil...Stansberry Research | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding iTeos Therapeutics, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share iTeos Therapeutics With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.